CopyMark Law Group
4.9/5
Drawing for EYONIS

USPTO serial 97702750

EYONIS

Reviewed by CopyMark Law Group

Reg. 7657176Status 700Registered
Filing date
Status date
Registration date
Jan 21, 2025
Examiner
BARREDA, AMBER KYLEE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EYONIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rebeccah Gan

Rebeccah Gan MUNCY, GEISSLER, OLDS & LOWE, P.C.125 S. ROYAL ST.ALEXANDRIA, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software for medical image analysis in the medical field; downloadable and recorded Software as a Medical Device (SaMD) for the analysis and processing of medical images to analyze, detect, recognize and classify organs and normal and abnormal anatomical structures of the human body, in the field of healthcare based on artificial intelligence and machine learning; downloadable and recorded software in the medical field, namely, software for the analysis and processing of medical images to analyze, detect, recognize and classify organs and normal and abnormal anatomical structures of the human body; downloadable and recorded artificial intelligence software in the medical field, namely, software for the analysis and processing of medical images to analyze, detect, recognize and classify organs and normal and abnormal anatomical structures of the human body; downloadable and recorded medical software for processing and displaying images from anatomical and functional imaging modalities on imaging machines; downloadable and recorded software for image, graphic and text processing in the medical field; downloadable and recorded digital image processing software providing anatomical and functional information for the diagnosis, analysis and processing of organs, normal and abnormal anatomical structures of the human body; downloadable and recorded Computer software for the analysis of digital images providing anatomical and functional information on the human body given by the diagnostic imaging equipment; downloadable and recorded computer software for the organization and visualization of digital images and photographs of organs and normal and abnormal anatomical structures of the human body; downloadable and recorded computer software for processing digital images and other multimedia files in the medical field; downloadable and recorded software to be used for encryption and decryption of digital files, namely, audio, video, text, binary, still images, graphics and multimedia files in the medical field; downloadable and recorded software for saving digital files, namely, audio, video, text, binary, still images, graphics and multimedia files in the medical field; computer hardware and downloadable and recorded software for medical imaging devices and for the analysis and processing of medical images to analyze, detect, recognize and classify organs and normal and abnormal anatomical structures of the human body, in the field of healthcare based on artificial intelligence and machine learning; downloadable and recorded software suitable for medical imaging equipment for the analysis and processing of medical images to analyze, detect, recognize and classify organs and normal and abnormal anatomical structures of the human body, in the field of healthcare based on artificial intelligence and machine learningACTIVE—
010Medical device for medical image analysis and processing Software as Medical Device (SaMD), namely, medical image processors, in the field of healthcare based on artificial intelligence and machine learningACTIVE—
035Management, collection, compilation and updating of information into computerized databases in the medical and pharmaceutical fields for medical diagnosis; management, collection, compilation and updating of information into computerized databases in the medical field for medical diagnosis, prognosis and therapeutic decision support; wholesale store services featuring software; retail store services featuring software for managing, collecting, compiling and updating medical data for medical diagnosis, prognosis and therapeutic decision supportACTIVE—
041Educational services, namely, providing classes, seminars in the field of medical imagingACTIVE—
042Temporary use of software providing a web access featuring temporary use of non-downloadable software for analyzing and processing medical images; providing clinical, medical and scientific research information in the field of medical imaging; clinical, medical and scientific research, namely, conducting clinical trials for others and developing a software as a medical device in the field of medical imaging using artificial intelligence and data science; Software as a service (SAAS) services featuring software for developing platforms using artificial intelligence and data science to leverage medical images and other clinical and media data, namely, audio, video, text, binary, still images, graphics and multimedia files in the medical field; Software as a Service (SAAS) services featuring software for analyzing and processing medical images; scientific and clinical research, namely, conducting clinical trials for others and developing of computer software for others as a medical device for medical purposes related to cancer and other diseases, namely, metabolic diseases; Platform as a service (PAAS) featuring computer software platforms for image editing; medical and scientific research, namely, conducting clinical trials for others; design, development, installation, maintenance, rental, and update of computer software in the medical field for collecting, analyzing and organizing data; design, development, installation, maintenance, rental and update of medical image processing computer software for assessing normal and abnormal anatomical structures of the human body; development, maintenance and rebuilding of computer software databases in the medical field; technical support services, namely, troubleshooting of computer software problems; providing temporary use of non-downloadable computer software for analyzing and processing medical images over computer networks, intranets and the Internet; Platforms as a service (PAAS) featuring computer software platforms for use in database managementACTIVE—
044Medical diagnosis and prognosis of cancers and metabolic diseases and providing therapeutic decision support services for cancer patients; medical image analysis services, namely, medical image analysis of clinical data, medical information, namely, for assessing normal and abnormal anatomical structures of the human body through audio, video, text, binary, still images, graphics and multimedia files, provided to healthcare professionals via the Internet and over global computer networks based on the use of medical images stored in data archiving and retrieval systems for scientific research purposes and developing a software as a medical device; consulting services in the field of medical imaging regarding conducting clinical trials for others and developing software as a medical device; providing online and offline medical information on the use of medical diagnostic imaging equipment; providing information, advice and data on medical imaging; medical imaging services for diagnosis and treatment of cancers and metabolic diseases; medical image analysis services, namely, medical images analysis for the diagnosis and prognosis of cancers and other pathologies, namely, metabolic diseases; consulting services in the field of medical imaging; medical imaging analysis services, namely, medical images analysis for clinical trials; personalized medical diagnostic and prognostic testing services for detecting and measuring antibody levels; medical information; imaging-based medical analysis services, namely, medical images analysis for diagnostic and treatment purposes provided by medical imaging departmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 3, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 3, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 11, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 13, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2023DOCKASSIGNED TO EXAMINER—
Sep 5, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 5, 2023ALIEASSIGNED TO LIE—
Apr 20, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 30, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance